1Ecker A, Riemenschneider PA. Arteriographic demonstration of spasm of the intracranial arteries: With special reference to saccular arterial aneurysm. J Neurosurg,1951, 8: 660-667.
2Kassell NF, Peerless S J, Durward QJ.Treatment of isehemic deficits from vasospasm with intracranial volume expansion and induced arterial hypertension. Neurosurgery. 1982, 11: 337-343.
3Solomon RA, Antunes JL, Chen RY. Decrease in cerebral blood flow in rats after experimental subarachnoid hemorrhage: a new animal model. Stroke, 1985, 16:58-64.
4Varsos VG, Liszczak TM, Han DH. Delayed cerebral vasospasm is not reversible byaminophylline, nifedipine, or papaverine in a 'two-hemorrhage' canine model. J Neurosurg, 1983, 58: 11-17.
5Takemae T, Branson J, Alksne JF. Intimal proliferation of cerebral arteries after subarachnoid blood injection in pigs. J Neurosurg, 1990, 72: 626-633.
6Macdonald RL, Wallace MC, Perry S.Pathological effects of angioplasty on vasospastic carotid arteries in a rabbit model. J Neurosurg, 1995, 83: 111-117.
7Okada T, Harada T, Bark DH. A rat femoral artery model for vasospasm. Neurosurgery,1990, 27:349-356.
8Simard JM, Kent TA. Vascular smooth muscle proliferation as a target for therapeutic intervention. Stroke, 2003, 34:108.
9Borel CO, MeKee A, Parra A, et al. Possible role for vascular cell proliferation in cerebral vasospasm after subarachnoid hemorrhage.Stroke, 2003,34:427-433.
10MeGirt MJ, Lynch JR, Blessing R. Serumy on Willebrand factor, matrix metalloproteinase-9, and vascular endothelial growth factor levels predict the onset of cerebral vasospasm after aneurysmal subaraehnoid hemorrhage. Neurosurgery, 2002, 51: 1128-1134.
